Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 404 - (OTC: SKDI), (CSE: FLYY), (CSE: HOLL), (NASDAQ: NEPT) (TSX: NEPT), (TSXV: YSS)
Delta, Kelowna, BC - April 23, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts, #Cannabis News and #Stocks on the Move; Episode 404 - (OTC: SKDI), (CSE: FLYY), (CSE: HOLL), (NASDAQ: NEPT) (TSX: NEPT), (TSXV: YSS)
Today's podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today's podcast will be looking at a few public company announcements.
Sun Kissed has guided Hakuna since the acquisition positioning them for significant growth via affiliate and other marketing avenues. With current annualized revenues of $1 million, Hakuna with Mr. Armenta is targeting X increased revenues for 2020.
"Sun Kissed Industries has exciting CBD product lines along with the recently announced Numuni digital content monetization acquisition. I bring my extensive expertise in brand growth and acquisition targets to Sun Kissed. Working with Carl Grant, and the Sun Kissed team, to execute their business plan will be an exciting endeavor," commented Mr. Armenta.
Carl Grant, CEO of Sun Kissed said "We are thrilled to have Mr. Armenta join our team. As one can see in his extensive bio (listed below), Mr. Armenta brings heavyweight affiliate marketing and corporate expansion experience to our company. He has already facilitated in the Numuni acquisition and we look forward to many more growth ventures with him."
Mr. Armenta brings over 19 years of industry experience to Sun Kissed Industries Inc. He originally owned Colorado Sports Innovations Consulting, which assisted companies in branding and revenue growth strategies. Mr. Armenta was the CEO of Intensity Nutrition, COO and Executive Vice President of MusclePharm, Vice President of Business Development for Inner Armour, Creative Edge Nutrition all leading nutritional brands in the industry.
While at MusclePharm he started as a consultant in sales and due to his success with helping the brand grow, was promoted to Chief Operating Officer and eventually promoted to Executive Vice President. Mr. Armenta was instrumental in the advancement of MusclePharm into becoming one of the leading U.S. nutritional Brands. Mr. Armenta was instrumental in placing MusclePharm into the largest US distributors and in over 35 International countries. He helped the company grow from $86,000 in sales in 2008, to being on pace to $77M sales in 2011.
Media Central Corporation Inc. (CSE: FLYY) today announced that its wholly owned property Canncentral.com will provide ongoing coverage of the burgeoning psychedelics sector. Canncentral is a digital magazine dedicated to covering the latest in cannabis news and lifestyle and is an authoritative voice in the complementary wellness market. Canncentral's psychedelics reporting will focus on the wide range of therapeutic and medical applications as well as business news, trends and legislative changes in the rapidly emerging area.
"The world of psychedelics is a natural extension of the content we produce at Canncentral," said Brian Kalish, CEO of MediaCentral. "Our 6.5 million audience of engaged influential readers have their fingers on the pulse of emerging trends and are eager to consume up-to-date information from our award-winning editorial teams. Early signs point to the huge impact that psychedelics will have on society from a cultural, medical and business perspective. This focus on psychedelics is a natural progression of our ongoing strategy to leverage our considerable audience and capitalize on the latest in material trends as we move to further monetize our titles."
A recent study by Data Bridge Market Research indicates the psychedelics market is experiencing a compound annual growth rate of approximately 16%. This is driven in part by the efficacy and impact expected from chemicals such as LSD and Ketamine in the antidepressant drug market alone, which is anticipated to exceed US$15.98 billion by 2023. As a result, many analysts have forecasted the potential of the psychedelics market to outpace cannabis as an investment class.
Canncentral will provide regular coverage on all things psychedelics and will distribute stories omnichannel to its growing audience through its own platform and MediaCentral's other titles including NOW Magazine in Toronto and Georgia Straight in Vancouver. Content around psychedelics will be integrated across the Company's full spectrum of three digital platforms, two print publications, three newsletters and nine social media channels accounting for nearly a million total followers.
Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF), a diversified cannabis branding company with products in over 220 dispensaries throughout California, announced that it has entered into a share exchange agreement dated April 22nd, 2020 among the Company, AlphaMind Brands Inc. and the shareholders of TargetCo, pursuant to which, the Company will acquire all of the issued and outstanding shares of TargetCo.
Alphamind Brands is a Canada and US based growth stage company, that is developing a portfolio of certified legal mushroom based natural health products. It is also actively conducting R&D initiatives, led by Dr. Nikos C. Apostolopoulos, who is exploring psilocybin based pharmaceutical treatments. The company's "ready to ship" product SKU's include Cordyceps, Lion's Mane, Shiitake, Oyster and Reishi Mushroom based: liquid tinctures, concentrated mushroom powder(s), teas, and chocolate.
"We are very pleased to have completed the next step in consummating this very exciting acquisition", shared Carl Saling, Founder and CEO of Hollister Biosciences, Inc. "It is a fundamental value of our company to improve the overall health and performance of our customers through our high-quality products and the health benefits associated with medicinal mushrooms are tremendous. Not to mention, it is our continual objective to broaden our product scope and Alphamind, with its experienced management team, is a perfect foothold for us in the fast-growing market for medicinal mushrooms and complements our existing cannabis and hemp-based product offering."
"I think we have found a great partner in Hollister", shared Robert Birmingham, CEO of Alphamind Brands. "We have medicinal mushroom based product SKU's ready to ship and R&D is underway to develop an exciting IP portfolio surrounding psilocybin based pharmaceutical treatments. Being under the Hollister umbrella will allow us to access additional markets and leverage their existing manufacturing and distribution infrastructure and will be a fundamental part of the future growth of our business."
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), a leader in natural health products, and its subsidiary Biodroga, is successfully accelerating production of hand sanitizers to over one million units weekly. Neptune's hand sanitizer gel kills 99.9% of germs and bacteria and is available in 2 oz, 4 oz, 6oz, 8 oz, 16 oz, 1 liter and 1 gallon formats.
Neptune has executed on scaling up hand sanitizer production ahead of schedule to rapidly increase critical supply and meet market demand driven by the COVID-19 pandemic. This scale up will allow Neptune to meet strong demand from its North American retail and government customers, and begin shipping product next week, including fulfilling a purchase order from a large North American retailer.
"I could not be more proud of how our entire team has mobilized to leverage our collective expertise in procurement, manufacturing, product innovation, supply chain management and regulatory affairs to bring significant and continuous supply of hand sanitizer gel to market ahead of schedule during this critical stage in the battle against COVID-19," said Michael Cammarata, Chief Executive Officer of Neptune Wellness Solutions. "We are rapidly responding to the needs of North Americans and playing a key role in meeting customer demand for safe and effective hand sanitizer to help prevent the spread of germs and protect consumer health."
For product and order inquiries, please contact: firstname.lastname@example.org or visit our website http://solutions.neptunecorp.com.
YSS Corp.™ (TSXV: YSS), a premier Canadian cannabis retailer with operations under the YSSTM and Sweet TreeTM brands and a trusted destination to explore and discover cannabis in Canada, announced that their YSS and Sweet Tree Cannabis stores in Alberta and Saskatchewan are now offering online ordering by way of Click-and-Collect through www.ysscorp.ca and www.sweettreecannabis.com.
This exciting rollout represents the next phase of convenience for YSS customers and further enhances in-store safety during the COVID-19 pandemic by enabling customers to minimize time in-store. With ease, customers can now browse and filter the company's complete inventory of available cannabis and cannabis-related accessories by store and reserve products from whichever location is most convenient. The online platform features an estimated time for pick-up and direct text order updates from the chosen store.
The Click-and-Collect service is a fully-compliant technology built on a secure, internally-controlled and Canadian-domiciled platform that allows customers to browse, shop and reserve under a personal profile or as a guest. All secure customer data is managed exclusively by YSS.
While trust has always been one of YSS' core business values, in the face of the COVID-19 pandemic, trust is prioritized more than ever. We care deeply about the safety and well-being of our employees, customers, and partners, and we have put measures in place to ensure a clean, safe and prompt retail experience. For more information on our COVID-19 response and to explore our "Click-and-Collect' portal, please visit us at the YSS website: www.ysscorp.ca.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android